Goldman Sachs analyst Duffy Fischer initiated coverage of FMC (FMC) with a Buy rating and $51 price target implying 28% upside. At current valuation levels, the firm sees “significant upside” if the company’s announced off-patent strategy for diamides goes to plan. The analyst also believes the Street is underestimating FMC’s future growth from new product launches in 2026 and 2027, evident in current consensus estimates sitting below the company’s 2027 guidance targets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC:
- DoorDash, TKO Group, Williams-Sonoma, Expand Energy to join S&P 500 on 3/24
- FMC price target lowered to $43 from $48 at Wells Fargo
- FMC price target lowered to $55 from $72 at Seaport Research
- FMC price target lowered to $51 from $55 at KeyBanc
- Levi & Korsinsky LLP Notifies Shareholders of FMC Corporation(FMC) of a Class Action Lawsuit and an Upcoming Deadline